CENDAKIMAB

UNII:	O8R9U9ZUVN
Formula:
Preferred Substance Name:	CENDAKIMAB

2151032-62-9
ABT-308
CC-93538
CENDAKIMAB [INN]
CENDAKIMAB [USAN]
CENDAKIMAB [WHO-DD]
HUMANIZED ANTI-HUMAN IL-13 MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL-13 (INTERLEUKIN 13, IL-13)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-453) (VH (HOMO SAPIENS IGHV2-5*08 (80.6%) -(IGHD) -IGHJ4*01 (100%)) (10.7.15) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (220) (124-221), HINGE (222-236), CH2 L1.3>A (240), L1.2>A (241) (237-346), CH3 E12 (362), M14 (364) (347-451), CHS (452-453)) (124-453)), (226-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (85.3%) - IGKJ4*01 (100%)) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (100%) A45.1 (153), V101 (191) (108'-214'))DIMER (232-232'':235-235'')- BISDISULFIDE
RPC-4046

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CENDAKIMAB

Synonyms and Mappings

Resources